Cargando…

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy

BACKGROUND: The overall treatment time of stereotactic body radiotherapy (SBRT) for non-small-cell lung cancer is usually 3 to over 10 days. If it is longer than 7 days, tumor volume expansion during SBRT may jeopardize the target dose coverage. In this study, volume change of stage I NSCLC during S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatekawa, Kotoha, Iwata, Hiromitsu, Kawaguchi, Takatsune, Ishikura, Satoshi, Baba, Fumiya, Otsuka, Shinya, Miyakawa, Akifumi, Iwana, Maho, Shibamoto, Yuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904205/ https://www.ncbi.nlm.nih.gov/pubmed/24393430 http://dx.doi.org/10.1186/1748-717X-9-8

Ejemplares similares

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results
por: Niwa, Masanari, et al.
Publicado: (2020)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

Applicability of the linear–quadratic model to single and fractionated radiotherapy schedules: an experimental study
por: Miyakawa, Akifumi, et al.
Publicado: (2014)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
por: Miyakawa, Akifumi, et al.
Publicado: (2017)

Stereotactic body radiotherapy using the forward-planned static-port tomotherapy for lung cancer: a novel planning technique with the newly-developed mode
por: Manabe, Yoshihiko, et al.
Publicado: (2020)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
por: Baba, Fumiya, et al.
Publicado: (2009)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy as an Alternative to Definitive Surgery in Cancers of Various Organs
por: Shibamoto, Yuta, et al.
Publicado: (2018)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations
por: Mori, Yoshimasa, et al.
Publicado: (2018)

Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
por: Iwata, Hiromitsu, et al.
Publicado: (2013)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
por: Shioyama, Yoshiyuki, et al.
Publicado: (2018)

Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy
por: Tomita, Natsuo, et al.
Publicado: (2020)

Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

Local radiotherapy for pleural dissemination of thymic tumors after initial treatment
por: Okazaki, Dai, et al.
Publicado: (2021)

Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
por: Nagai, Aiko, et al.
Publicado: (2014)

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2014)

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer
por: Nakajima, Koichiro, et al.
Publicado: (2018)

Safety and Efficacy of Intensity-Modulated Stereotactic Body Radiotherapy Using Helical Tomotherapy for Lung Cancer and Lung Metastasis
por: Nagai, Aiko, et al.
Publicado: (2014)

Utility of CT texture analysis to differentiate olfactory neuroblastoma from sinonasal squamous cell carcinoma
por: Ogawa, Masaki, et al.
Publicado: (2021)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Comparative Analysis of Photon Stereotactic Radiotherapy and Carbon-Ion Radiotherapy for Elderly Patients with Stage I Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
por: Aoki, Shuri, et al.
Publicado: (2023)

STEREOTACTIC RADIOTHERAPY FOR SPINAL INTRADURAL METASTASES DEVELOPING WITHIN OR ADJACENT TO THE PREVIOUS IRRADIATION FIELD – REPORT OF THREE CASES –
por: MORI, YOSHIMASA, et al.
Publicado: (2013)

Definitive radiotherapy with stereotactic or IMRT boost with or without radiosensitization strategy for operable breast cancer patients who refuse surgery
por: Shibamoto, Yuta, et al.
Publicado: (2022)

Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly‐developed tumor‐tracking system and cyberknife
por: Manabe, Yoshihiko, et al.
Publicado: (2021)

Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
por: Murai, Taro, et al.
Publicado: (2016)

Internal Carotid Artery Blister-Like Aneurysm Caused by Aspergillus – Case Report
por: Ogawa, Masaki, et al.
Publicado: (2015)

Radiotherapy for a rare phosphaturic mesenchymal tumor in the middle ear presenting with oncogenic osteomalacia: A case report
por: Takaoka, Taiki, et al.
Publicado: (2021)

Impact on dose distribution and volume changes of a bioabsorbable polyglycolic acid spacer during chemo-proton therapy for a pediatric Ewing sarcoma
por: Kimura, Mitsuhiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lmgfhnumj71uvpvg58j51l7mnr